Forget Oral Wegovy: This Could Be a Bigger Win for Investors
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Knowing when to switch from aggressive to conservative investing is key. Understand the signs that indicate it's time to adjust your strategy.
14,440 articlesThe launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Investors are looking at SMH with fresh eyes as AI infrastructure expands. This article explains why a bold predictio...
Investors brace for potential disruption as Trump-Iran brinkmanship over the Strait of Hormuz raises the risk of oil ...
Ciena shares surged on Monday thanks to upbeat analyst revisions and higher price targets. This article breaks down w...
A big investor recently unloaded $7.8 million worth of Harrow stock. This article breaks down whether that move signa...
A high-profile insider trade grabbed headlines: c3.ai's executive chairman dumped thousands of shares for millions of...
A former employee has filed a class-action complaint against US Mortgage Corp. over a May 2025 data breach that expos...
Kharg Island, a key Iran oil export hub, is under the spotlight as geopolitical tensions heighten risk to energy flow...
One of Wall Street’s hottest hedge funds is riding a two-trade surge, concentrated in Nvidia and Meta Platforms, as i...
Insider buying can hint at confidence from leadership, but it isn’t a crystal ball. This guide explains how to interp...
ARTY leads humanoid-robot ETFs in 2026, outpacing BOTT and ROBO as investors chase AI software momentum. This shift h...
A notable stake reduction in NMI Holdings highlights how large investors weigh growth, risk, and value. Here’s what i...